Challenges and Opportunities for the Prevention and Treatment of Cardiovascular Disease Among Young Adults: Report From a National Heart, Lung, and Blood Institute Working Group
Why the study?
Improvements in CVD rates among young adults have been offset by disparities and persistent risk factors, yet few trials have evaluated CVD prevention and treatment in individuals under 40 years old.
Structured PICO
P
Population
Young adults 18 to 39 years old
This NHLBI working group report outlines critical research gaps and opportunities for preventing and treating cardiovascular disease in young adults aged 18 to 39.
Authors
Discussion
No takes yet. Share an insight, caveat, or question.
Implication
Should not yet change practice in young adults; leaves open optimal prevention strategies for targeted trials.
Cite This Study
Gooding et al. (2020) studied this question.